Reliability and Validity of Thai Calgary Depression Scale of Schizophrenia (CDSS)
NCT ID: NCT01590784
Last Updated: 2016-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2012-01-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to a.) test the reliability and validity of the Thai version of Calgary depression scale of schizophrenia (CDSS) and b.) identify the prevalence and factors associated with depression in patients with schizophrenia including quality of life, type of antipsychotic drugs, and severity of schizophrenia in 60 patients with schizophrenia at the Faculty of Medicine, Chiang Mai University, Thailand.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
NCT06278532
Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia
NCT01587521
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
NCT00155519
Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients
NCT07165821
Improving Insight in Patients Diagnosed With Schizophrenia
NCT01282307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Thai version of Calgary depression scale of schizophrenia (CDSS), Positive and Negative Syndrome Scale (PANSS), Hamilton Rating Scale for Depression-17 (HAM-D 17), Montgomery-Asberg Depression Rating Scale (MADRS), the Thai abbreviated version of World Health Organization quality of life (WHOQOL-BREF-THAI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of schizophrenia according to DSM-IV-TR
Exclusion Criteria
* Not fluent in Thai
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chiang Mai University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sirijit Suttajit
University instructor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sirijit Suttajit, MD, MSc
Role: STUDY_DIRECTOR
Chiang Mai University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chiang Mai University
Chiang Mai, Chiang Mai, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSY-11-09-09-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.